| Financial Year |
March 31 2023 |
| Monetary Funds |
501,419,499.56 |
| Held-for-trading Financial Assets |
82,221,865.44 |
| Notes Receivable |
-- |
| Accounts Receivable |
44,994,254.08 |
| Advances to Suppliers |
22,533,415.07 |
| Other Receivables |
8,979,659.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
270,287,830.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,009,530.73 |
| Total Current Assets |
966,339,597.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
356,839,298.03 |
| Under-construction Projects |
132,222,218.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
171,712,198.47 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,776,891.08 |
| Other Non-Current Assets |
151,407,408.92 |
| Sub-Total of Non-Current Assets |
988,655,641.56 |
| Total Assets |
1,954,995,238.89 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
84,906,207.11 |
| Accounts Received In Advance |
6,213,177.70 |
| Employee Compensation Payable |
4,769,720.73 |
| Taxes Payable |
11,412,148.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,241,693.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
486,247.33 |
| Other Current Liabilities |
13,616,577.10 |
| Sub-Total of Current Liabilities |
274,723,863.10 |
| Long-term Loans |
2,422,250.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,422,250.74 |
| Total Liabilities |
277,146,113.84 |
| Paid-In Capital(Or Share Stock) |
430,000,018.00 |
| Capital Surplus |
574,442,131.85 |
| Surplus Reserve |
70,622,713.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
564,378,292.93 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,677,849,125.05 |
| Owner's Equity（Stockholder's Equity） |
1,677,849,125.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,954,995,238.89 |
